A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity

Clinical trial NCT01945684 · COMPLETED

Trial details

NCT number: NCT01945684
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Spasticity Stroke

Start date: 2013-09-01
Primary completion: 2014-05-01
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.